Most Undervalued Stocks Based on Pattern Recognition: up to 62.74% Return in 3 Days

Most Undervalued Stocks

This most undervalued stocks forecast is designed for investors and analysts who need predictions of the best pharma stocks for the whole pharmaceutical sector (See Pharma Package). It includes 20 stocks with bullish and bearish signals and indicates the best pharmaceutical stocks to buy:

  • Top 10 pharmaceutical stocks for the long position
  • Top 10 pharmaceutical stocks for the short position

Pharma Stocks ForecastPackage Name: Pharma Package
Forecast Length: 3 Days (05/13/16 – 05/17/16)
I Know First Average: 8.81%

most undervalued stocks

7 out of 10 top stock picks from the algorithm increased as predicted for this short-term forecasting period. ANAC saw monumental growth of 62.74% in just 3 days. REGN, PPHM, and AGN also had excellent performances with returns of 5.67%, 5.56%, and 5.35% respectively. This 3-day forecast had overall growth of 8.81% offering investors an advantage over the S&P 500’s negative return of -0.82%.

Anacor Pharmaceuticals, Inc. (ANAC), a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Pfizer is going to be buying Anacor for its eczema drug that could be a “potential blockbuster”. Pfizer recently announced that it will acquire Anacor Pharmaceuticals (ANAC) for $4.5 billion, since the announcement the stock has gone up by more than 62%.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First algorithmic traders.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.